Drug
Telavancin
Telavancin: highest development phase Phase 2, developed by Theravance Biopharma. 2 trial records tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Theravance Biopharma
Trials
| Drug | Phase | Indication |
|---|---|---|
| Telavancin NCT01321879 | Phase 2 | Infection |
| Telavancin NCT02753855 | Phase 1 | Healthy |
Latest
No recent events.
Follow Telavancin on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.